Thomas Carroll

5.0k total citations
22 papers, 1.1k citations indexed

About

Thomas Carroll is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Thomas Carroll has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Thomas Carroll's work include RNA modifications and cancer (4 papers), interferon and immune responses (3 papers) and Cancer-related Molecular Pathways (3 papers). Thomas Carroll is often cited by papers focused on RNA modifications and cancer (4 papers), interferon and immune responses (3 papers) and Cancer-related Molecular Pathways (3 papers). Thomas Carroll collaborates with scholars based in United States, United Kingdom and Germany. Thomas Carroll's co-authors include Ji‐Dung Luo, Christian Zierhut, Hironori Funabiki, Norihiro Yamaguchi, Arnau Hervera, Ajay M. Shah, Célio X.C. Santos, Alexander Kapustin, Luming Zhou and Elena Tantardini and has published in prestigious journals such as Cell, The Lancet and Nature Communications.

In The Last Decade

Thomas Carroll

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Carroll United States 15 655 346 172 107 92 22 1.1k
Ya Cui China 17 730 1.1× 260 0.8× 270 1.6× 135 1.3× 68 0.7× 44 1.2k
Yingchi Zhang China 16 417 0.6× 184 0.5× 124 0.7× 121 1.1× 57 0.6× 68 937
Yedi Zhou China 22 687 1.0× 269 0.8× 294 1.7× 53 0.5× 90 1.0× 70 1.5k
So‐Hee Hong South Korea 18 381 0.6× 249 0.7× 102 0.6× 118 1.1× 49 0.5× 50 931
Eliana Abdelhay Brazil 16 379 0.6× 180 0.5× 73 0.4× 142 1.3× 31 0.3× 55 854
Gabriele Bucci Italy 15 1.1k 1.6× 272 0.8× 382 2.2× 129 1.2× 77 0.8× 28 1.6k
Ivan Peng United States 12 444 0.7× 535 1.5× 108 0.6× 130 1.2× 68 0.7× 12 1.2k
Christoph Peter Germany 20 957 1.5× 392 1.1× 117 0.7× 87 0.8× 79 0.9× 50 1.6k
Martha Robles‐Flores Mexico 19 663 1.0× 125 0.4× 141 0.8× 181 1.7× 39 0.4× 52 1.0k
Francesca Rapino Belgium 14 1.2k 1.8× 428 1.2× 131 0.8× 123 1.1× 47 0.5× 20 1.4k

Countries citing papers authored by Thomas Carroll

Since Specialization
Citations

This map shows the geographic impact of Thomas Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Carroll more than expected).

Fields of papers citing papers by Thomas Carroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Carroll. The network helps show where Thomas Carroll may publish in the future.

Co-authorship network of co-authors of Thomas Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Carroll. A scholar is included among the top collaborators of Thomas Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Carroll. Thomas Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akama‐Garren, Elliot H., Paul Miller, Thomas Carroll, et al.. (2023). Regulation of immunological tolerance by the p53-inhibitor iASPP. Cell Death and Disease. 14(2). 84–84. 6 indexed citations
2.
Irmady, Krithi, Caryn Hale, John J. Fak, et al.. (2023). Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease. Nature Communications. 14(1). 3956–3956. 23 indexed citations
3.
Miller, Paul, Elliot H. Akama‐Garren, Richard Owen, et al.. (2023). p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer. Cell Death and Differentiation. 30(7). 1619–1635. 5 indexed citations
4.
Moussawi, Khatoun Al, Thomas Carroll, Christian Osterburg, et al.. (2022). Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis. Cell Reports. 41(3). 111503–111503. 8 indexed citations
5.
Rozen-Gagnon, Kathryn, Meigang Gu, Joseph M. Luna, et al.. (2021). Argonaute-CLIP delineates versatile, functional RNAi networks in Aedes aegypti, a major vector of human viruses. Cell Host & Microbe. 29(5). 834–848.e13. 9 indexed citations
6.
Williamson, Christina, Rohiverth Guarecuco, Leah Gates, et al.. (2020). ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-Asparaginase. Cell Metabolism. 31(4). 852–861.e6. 52 indexed citations
7.
Xi, Linghe, Thomas Carroll, Irina Matos, et al.. (2020). m6A RNA methylation impacts fate choices during skin morphogenesis. eLife. 9. 31 indexed citations
8.
Tran, Maxine, B. Bibby, Lingjian Yang, et al.. (2020). Independence of HIF1a and androgen signaling pathways in prostate cancer. BMC Cancer. 20(1). 469–469. 28 indexed citations
9.
Uribe‐Lewis, Santiago, Thomas Carroll, Suraj Menon, et al.. (2020). 5-hydroxymethylcytosine and gene activity in mouse intestinal differentiation. Scientific Reports. 10(1). 546–546. 21 indexed citations
10.
Davison, Laura, Jessie Liu, Lei Huang, et al.. (2019). Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice. Frontiers in Immunology. 10. 2017–2017. 9 indexed citations
11.
Zierhut, Christian, et al.. (2019). The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death. Cell. 178(2). 302–315.e23. 303 indexed citations
12.
Yoney, Anna, Fred Etoc, Albert Ruzo, et al.. (2018). WNT signaling memory is required for ACTIVIN to function as a morphogen in human gastruloids. eLife. 7. 55 indexed citations
13.
Hervera, Arnau, Francesco De Virgiliis, Ilaria Palmisano, et al.. (2018). Reactive oxygen species regulate axonal regeneration through the release of exosomal NADPH oxidase 2 complexes into injured axons. Nature Cell Biology. 20(3). 307–319. 247 indexed citations
14.
Perea, Daniel, Jordi Guiu, Bruno Hudry, et al.. (2017). Ret receptor tyrosine kinase sustains proliferation and tissue maturation in intestinal epithelia. The EMBO Journal. 36(20). 3029–3045. 25 indexed citations
15.
Graham, Bryony, Antoine Marçais, Gopuraja Dharmalingam, et al.. (2016). MicroRNAs of the miR-290–295 Family Maintain Bivalency in Mouse Embryonic Stem Cells. Stem Cell Reports. 6(5). 635–642. 21 indexed citations
16.
Robinson, Jill O., Thomas Carroll, Lindsay Z. Feuerman, et al.. (2016). Participants and Study Decliners’ Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing. Journal of Empirical Research on Human Research Ethics. 11(1). 21–30. 39 indexed citations
17.
Bruno, Ludovica, Thomas Carroll, James I. Elliott, et al.. (2015). microRNAs Regulate Cell-to-Cell Variability of Endogenous Target Gene Expression in Developing Mouse Thymocytes. PLoS Genetics. 11(2). e1005020–e1005020. 17 indexed citations
18.
Lamb, Alastair, Antonio Ramos‐Montoya, Roslin Russell, et al.. (2014). Role of Hes6 in castration-resistant prostate cancer. The Lancet. 383. S67–S67. 1 indexed citations
19.
Robinson, Jessica, Theresa E. Hickey, Anne Y. Warren, et al.. (2013). Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype. Oncogene. 33(50). 5666–5674. 64 indexed citations
20.
Carroll, Thomas. (2008). Germination protease: An atypical aspartic acid protease in Bacillus and Clostridium. OpenCommons - UConn (University of Connecticut). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026